Kinney Gene G.
SEC CIK 1564380 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PUBLIC LTD CO | Pres, CEO, Dir | 152.8K | — | $6.86M | 17 | 2022-07-27 | 2026-07-28 |
Most active insiders at PRTA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SCULLY WILLIAM P | 10% | $4.96M | — |
| 2 | Isaacs Michael John | GC, Company Sec | — | $71.1K |
| 3 | Kingston Anne Evans | Chief Strategy Off | — | $64.9K |
| 4 | Swanson Chad J. | Chief Development Off | — | — |
| 5 | Smith Brandon S. | COO | — | — |
| 6 | Zago Wagner M. | CSO | — | — |
| 7 | Kinney Gene G. | Pres, CEO, Dir | — | — |
| 8 | Walker Karin L | CAO | — | — |
| 9 | Nguyen Tran | CFO, Chief Strategy Off | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-30 20:31 | 2026-07-28 | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO, Dir | M - OptEx | — | +84.0K | 152.8K | +122% | — |
| D | 2026-07-30 20:31 | 2026-07-28 | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO, Dir | D - Sale to Iss | $8.56 | -84.0K | 68.8K | -55% | -$719.0K |
| 2025-07-30 | 2025-07-28 | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO, Dir | A - Grant | $0.00 | +140.0K | 152.8K | +1,094% | $0 | |
| DMT | 2023-05-17 | 2023-05-17 | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO | S - Sale+OE | $73.69 | -45.0K | 27.7K | -62% | -$3.32M |
| DT | 2023-05-17 | 2023-05-17 | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO | M - OptEx | $29.81 | +45.0K | 57.8K | +352% | +$1.34M |
| DM | 2022-09-30 | 2022-09-28 | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO | S - Sale+OE | $53.38 | -16.4K | 25.1K | -39% | -$876.0K |
| D | 2022-09-30 | 2022-09-28 | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO | M - OptEx | $6.41 | +16.4K | 29.2K | +128% | +$105.2K |
| D | 2022-09-23 | 2022-09-21 | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO | S - Sale+OE | $32.02 | -2,720 | 12.8K | -18% | -$87.1K |
| D | 2022-09-23 | 2022-09-21 | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO | M - OptEx | $6.41 | +2,720 | 15.5K | +21% | +$17.4K |
| D | 2022-08-19 | 2022-08-17 | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO | M - OptEx | $6.41 | +2,181 | 15.0K | +17% | +$14.0K |
| D | 2022-08-19 | 2022-08-17 | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO | S - Sale+OE | $32.03 | -2,181 | 12.8K | -15% | -$69.9K |
| DM | 2022-08-12 | 2022-08-10+ | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO | M - OptEx | $6.41 | +34.9K | 26.4K | New | +$223.9K |
| DM | 2022-08-12 | 2022-08-10+ | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO | S - Sale+OE | $32.16 | -34.9K | 12.8K | -73% | -$1.12M |
| DM | 2022-08-05 | 2022-08-04+ | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO | S - Sale+OE | $32.51 | -42.5K | 12.8K | -77% | -$1.38M |
| DM | 2022-08-05 | 2022-08-04+ | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO | M - OptEx | $6.41 | +42.5K | 33.7K | New | +$272.2K |
| D | 2022-07-29 | 2022-07-27 | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO | M - OptEx | $6.41 | +376 | 13.2K | +3% | +$2,410 |
| D | 2022-07-29 | 2022-07-27 | PRTA | PROTHENA CORP PUBLIC LTD CO | Kinney Gene G. | Pres, CEO | S - Sale+OE | $32.00 | -376 | 12.8K | -3% | -$12.0K |
Purchase Sale Sale after option exercise All abbreviations